Bitcoin Tumbles Below This Key Level; Injective Becomes Top Loser

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices trading below the key $28,000 level on Monday. Ethereum (CRYPTO: ETH) also moved lower, trading below the key $1,900 mark this morning.

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices trading below the key $28,000 level on Monday.

Ethereum (CRYPTO: ETH) also moved lower, trading below the key $1,900 mark this morning.

The Chicago Fed National Activity Index came in unchanged at -0.19 in March, but down from market expectations of -0.02.

Stacks (CRYPTO: INJ) turned out to be the biggest loser.

At the time of writing, the global crypto market cap fell to $1.16 trillion, recording a 24-hour decline of 0.8%. BTC was trading lower by 0.7% at $27,467 while ETH fell by around 1.4% to $1,850 on Monday.

Here are the top ten crypto gainers and losers over the past 24 hours:

Gainers

  • Stacks (CRYPTO: STX)

Price: $0.7481
24-hour gain: 3.3%

  • Render Token (CRYPTO: RNDR)

Price: $1.77
24-hour gain: 2.1%

  • Gemini Dollar (CRYPTO: GUSD)

Price: $1.01
24-hour gain: 1.9%

  • Frax Share (CRYPTO: FXS)

Price: $8.21
24-hour gain: 1.7%

  • Lido DAO (CRYPTO: LDO)

Price: $2.13
24-hour gain: 1.3%

Losers

  • Injective (CRYPTO: INJ)

Price: $6.58
24-hour drop: 12.6%

  • WOO Network (CRYPTO: WOO)

Price: $0.2495
24-hour drop: 11.6%

  • PancakeSwap (CRYPTO: CAKE)

Price: $2.99
24-hour drop: 11.3%

  • Arbitrum (CRYPTO: ARB)

Price: $1.33
24-hour drop: 8.2%

  • Zilliqa (CRYPTO: ZIL)

Price: $0.03122
24-hour drop: 5.8%

Read This Next: Microsoft To Rally Over 13%? Here Are 10 Other Analyst Forecasts For Monday

Total
0
Shares
Related Posts
Read More

Corcept Therapeutics Provides Financial Update And Announces $200M Stock Repurchase Program; Sees Q4 Revenue $135.4M Vs $127.85M Est.; FY23 Revenue $482.4M Vs $474.82M Est.; FY24 Revenue $600M–$630M Vs $513.85M Est.

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating

CORT